HCA HCA HEALTHCARE INC revenue, earnings and financials

For the quarter ended June 30, 2026, HCA HEALTHCARE INC reported revenue of $20.2B (up 8.7% from a year earlier), net income of $1.70B and diluted EPS of $7.62; over the last four quarters revenue was $78.0B and net income $6.84B; for the fiscal year ended December 2025 revenue was $75.6B, up 7.1% on the year before.

HCA annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $75.6B, gross profit n/a, operating income n/a, net income $6.78B (margin 9.0%), EPS $28.33
• Fiscal year ended Dec 2024: revenue $70.6B, gross profit n/a, operating income n/a, net income $5.76B (margin 8.2%), EPS $22.00
• Fiscal year ended Dec 2023: revenue $65.0B, gross profit n/a, operating income n/a, net income $5.24B (margin 8.1%), EPS $18.97
• Fiscal year ended Dec 2022: revenue $60.2B, gross profit n/a, operating income n/a, net income $5.64B (margin 9.4%), EPS $19.15
• Fiscal year ended Dec 2021: revenue $58.8B, gross profit n/a, operating income n/a, net income $6.96B (margin 11.8%), EPS $21.16

HCA quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $20.2B (up 8.7% year over year), net income $1.70B, EPS $7.62
• Quarter ended Mar 31, 2026: revenue $19.1B (up 4.3% year over year), net income $1.62B, EPS $7.15
• Quarter ended Dec 31, 2025 (from the annual report): revenue $19.5B (up 6.7% year over year), net income $1.88B, EPS $8.09
• Quarter ended Sep 30, 2025: revenue $19.2B (up 9.6% year over year), net income $1.64B, EPS $6.96
• Quarter ended Jun 30, 2025: revenue $18.6B (up 6.4% year over year), net income $1.65B, EPS $6.83
• Quarter ended Mar 31, 2025: revenue $18.3B (up 5.7% year over year), net income $1.61B, EPS $6.45
• Quarter ended Dec 31, 2024 (from the annual report): revenue $18.3B (up 5.7% year over year), net income $1.44B, EPS $5.66
• Quarter ended Sep 30, 2024: revenue $17.5B (up 7.9% year over year), net income $1.27B, EPS $4.88
• Quarter ended Jun 30, 2024: revenue $17.5B (up 10.3% year over year), net income $1.46B, EPS $5.53
• Quarter ended Mar 31, 2024: revenue $17.3B (up 11.2% year over year), net income $1.59B, EPS $5.93
• Quarter ended Dec 31, 2023 (from the annual report): revenue $17.3B (up 11.7% year over year), net income $1.61B, EPS $5.92
• Quarter ended Sep 30, 2023: revenue $16.2B (up 8.3% year over year), net income $1.08B, EPS $3.91
• Quarter ended Jun 30, 2023: revenue $15.9B (up 7.0% year over year), net income $1.19B, EPS $4.29
• Quarter ended Mar 31, 2023: revenue $15.6B (up 4.3% year over year), net income $1.36B, EPS $4.85
• Quarter ended Dec 31, 2022 (from the annual report): revenue $15.5B (up 2.9% year over year), net income $2.08B, EPS $7.20
• Quarter ended Sep 30, 2022: revenue $15.0B (down 2.0% year over year), net income $1.13B, EPS $3.91
• Quarter ended Jun 30, 2022: revenue $14.8B (up 2.7% year over year), net income $1.16B, EPS $3.90
• Quarter ended Mar 31, 2022: revenue $14.9B (up 6.9% year over year), net income $1.27B, EPS $4.14
• Quarter ended Dec 31, 2021 (from the annual report): revenue $15.1B, net income $1.81B, EPS $5.66
• Quarter ended Sep 30, 2021: revenue $15.3B, net income $2.27B, EPS $7.00

HCA cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $12.6B, share buybacks $10.1B, dividends $2.88 per share
• Fiscal year ended Dec 2024: operating cash flow $10.5B, share buybacks $6.04B, dividends $2.64 per share
• Fiscal year ended Dec 2023: operating cash flow $9.43B, share buybacks $3.81B, dividends $2.40 per share
• Fiscal year ended Dec 2022: operating cash flow $8.52B, share buybacks $7.00B, dividends $2.24 per share
• Fiscal year ended Dec 2021: operating cash flow $8.96B, share buybacks $8.22B, dividends $1.92 per share

HCA balance sheet

• Jun 30, 2026: cash $1.01B, total assets $63.3B, total liabilities n/a, shareholders' equity −$6.64B, long-term debt $43.5B
• Mar 31, 2026: cash $940M, total assets $61.5B, total liabilities n/a, shareholders' equity −$6.30B, long-term debt $39.5B
• Dec 31, 2025: cash $1.04B, total assets $60.7B, total liabilities n/a, shareholders' equity −$6.03B, long-term debt $41.6B
• Sep 30, 2025: cash $997M, total assets $59.7B, total liabilities n/a, shareholders' equity −$5.34B, long-term debt $38.4B
• Jun 30, 2025: cash $939M, total assets $59.5B, total liabilities n/a, shareholders' equity −$4.39B, long-term debt $39.4B
• Mar 31, 2025: cash $1.06B, total assets $59.8B, total liabilities n/a, shareholders' equity −$3.52B, long-term debt $41.1B
• Dec 31, 2024: cash $1.93B, total assets $59.5B, total liabilities n/a, shareholders' equity −$2.50B, long-term debt $38.3B
• Sep 30, 2024: cash $2.89B, total assets $59.5B, total liabilities n/a, shareholders' equity −$2.18B, long-term debt $38.3B

What is HCA's revenue?

HCA HEALTHCARE INC reported $78.0B of revenue over its last four quarters, through June 30, 2026.

Is HCA profitable?

Yes. HCA HEALTHCARE INC earned $6.84B over the last four quarters.

What is HCA's EPS?

Diluted earnings per share over the last four quarters were $29.82; $7.62 in the latest quarter.

Does HCA pay a dividend?

HCA HEALTHCARE INC paid $2.88 per share in dividends in the fiscal year ended December 2025.

HCA ownership and insider trades · All stocks